Página 5 - Melhores Cancro da mama médicos - TOP-171 médicos

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Dr. Kinas é especializado em cirurgia mamária e procedimentos oncológicos, oferecendo cuidados especializados nos Hospitais Büyük Anadolu.

• Experiente em várias cirurgias oncológicas, incluindo mama, pâncreas e cólon
• Especializado em cirurgias bariátricas metabólicas e de diabetes
• Focado em planos abrangentes de tratamento de câncer

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

A Dra. Kaduri especializa-se na investigação do cancro da mama relacionado com o BRCA, com estudos publicados sobre o Oncotype Dx em portadoras de BRCA1/2. Trabalha no Hadassah Medical Center.

• Realizar investigação inovadora no The Royal Marsden Hospital
• Publicar sobre mutações TP53 em doentes de ascendência árabe
• Ser galardoada com o prémio da Cancer Genetics Research Foundation
• Ser membro da Sociedade Israelita de Oncologia Clínica

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Especialista no tratamento do cancro da mama com experiência da Universidade Hacettepe – um dos principais centros de oncologia da Turquia.

• Especialista em oncologia médica com experiência no Hospital de Oncologia da Faculdade de Medicina da Universidade Hacettepe
• Membro titular da ESMO (European Society for Medical Oncology)
• Formado pela Faculdade de Medicina da Universidade de Ancara
• Tratar também cancros gastrointestinais, linfomas e sarcomas

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

322 publicações revisadas por pares – O Dr. Kuemmel chefia a Unidade Multidisciplinar de Mama da Alemanha no Kliniken Essen-Mitte.

• Diretor Clínico de um dos principais centros de câncer de mama da Alemanha
• Membro do Conselho Executivo da Arbeitsgemeinschaft Gynäkologische Onkologie
• Membro da faculdade da ESMO com 1.032 palestras convidadas em todo o mundo
• Especializar-se em programas de tratamento holístico do câncer de mama

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

O Dr. Leng Yin é especialista no tratamento do cancro da mama, bem como em oncologia do fígado, vesícula biliar e pâncreas no Fuda Cancer Hospital.

• Oncologista no Bumrungrad International Hospital e no Royal Siriraj Hospital, na Tailândia
• Membro da Associação Chinesa Anti-Cancro
• Especialização em múltiplos tratamentos de oncologia gastrointestinal e mamária

A Dra. Rinat Erushalmi é especialista em cancro da mama no Rabin Medical Center, com especialização em Cancro da Mama HER-2 Positivo e Triplo-Negativo.

• Altamente classificada em 6 condições, incluindo cancro da mama
• Especialista em Terapia de Reposição Hormonal e Ooforectomia
• Atua no Rabin Medical Center em Petach Tikva, Israel

25 anos de especialização em cancro da mama – A Dra. Viktoriya Nejman chefia o departamento de cirurgia oncológica do Rabin Medical Center, em Israel.

• Especialista em quimioterapia e tratamento cirúrgico do cancro da mama
• Membro de sociedades de oncologia nacionais e internacionais
• Líder de estudos clínicos em oncourologia
• Frequentemente convidada para palestrar em fóruns oncológicos internacionais

O Dr. Prat é especialista em expressão génica e subtipos moleculares de cancro da mama, desenvolvendo novos tratamentos na SOLTI. A sua investigação orienta diretamente o tratamento dos doentes.

• Chefe de Genómica Translacional no IDIBAPS
• Presidente da SOLTI – líder em ensaios clínicos de cancro da mama
• Mais de 160 publicações com 13.479 citações
• Professor titular na Universidade de Barcelona

Oncoginecologista com especialitas em cancro da mama no Samsung Medical Center.

• Especializado em cancros ginecológicos e cancro da mama
• Associado a um centro médico de referência na Coreia do Sul
• Focado no tratamento oncológico abrangente

Seung Jae Huh é um oncologista dedicado no Samsung Medical Center, especializado em cancro da mama.

• Especializar-se no tratamento do cancro da mama
• Praticar no Samsung Medical Center

Oncologista especializado em cancro da mama no Samsung Medical Center.

• Diagnosticar e tratar vários tipos de cancro da mama
• Trabalhar num dos principais centros médicos da Coreia do Sul
• Focar-se na elaboração de planos de tratamento personalizados